Edinburgh and London, UK, 13 June 2024 – Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company developing macrophage cell therapies to treat end-stage liver ...
Resolution leadership team joined by world leading clinical hepatologist Elliot Tapper, MD, FAASLD, and EMERALD Chief Investigator Professor Jonathan Fallowfield EDINBURGH, Scotland and LONDON, Aug.
EDINBURGH, Scotland and LONDON, Aug. 27, 2025 /PRNewswire/ --Resolution Therapeutics ("Resolution" or "Company"), a clinical-stage biopharmaceutical company pioneering regenerative macrophage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results